These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1471449)

  • 21. Acromesomelic Dysplasia, Type Maroteaux: Impact of Long-Term (8 Years) High-Dose Growth Hormone Treatment on Growth Velocity and Final Height in 2 Siblings.
    Arya VB; Raj M; Younes M; Chapman S; Irving M; Kapoor RR; Buchanan CR
    Horm Res Paediatr; 2020; 93(5):335-342. PubMed ID: 33238275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of two years of growth hormone treatment in short, slowly growing non-growth hormone deficient children.
    Lanes R
    J Pediatr Endocrinol Metab; 1995; 8(3):167-71. PubMed ID: 8521190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy.
    Hopwood NJ; Hintz RL; Gertner JM; Attie KM; Johanson AJ; Baptista J; Kuntze J; Blizzard RM; Cara JF; Chernausek SD
    J Pediatr; 1993 Aug; 123(2):215-22. PubMed ID: 8345416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Height gain at adult-height age in 184 short patients treated with growth hormone from prepubertal age to near adult-height age is not related to GH secretory status at GH therapy onset.
    Carrascosa A; Audí L; Fernández-Cancio M; Yeste D; Gussinye M; Campos A; Albisu MA; Clemente M; Bel J; Nosás R; Rabanal M; Del Pozo C; Gómez JM; Mesa J;
    Horm Res Paediatr; 2013; 79():145-56. PubMed ID: 23548791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A; Simon D; Czernichow P
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult height in patients treated for isolated growth hormone deficiency: role of birth weight.
    Di Cesare Merlone A; Bozzola E; Castelnovi C; Chiabotto P; Costante L; De Sanctis L; Tinelli C; Bozzola M
    Horm Res; 2005; 63(2):102-6. PubMed ID: 15767761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age.
    Carrascosa A; Audí L; Fernández-Cancio M; Esteban C; Andaluz P; Vilaró E; Clemente M; Yeste D; Albisu MA; Gussinyé M
    J Clin Endocrinol Metab; 2008 Mar; 93(3):764-70. PubMed ID: 18160465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined use of growth hormone and gonadotropin-releasing hormone analogue in short normal adolescent girls: a survey from Iran.
    Karamizadeh Z; Kashef MA; Jalaeian H; Namazee N
    Kaohsiung J Med Sci; 2006 Apr; 22(4):161-5. PubMed ID: 16679296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships between puberty and growth at adolescence in growth-hormone-deficient males: effect of growth hormone and of associated gonadal suppression therapy.
    Tanaka T; Yoshizawa A; Tanae A; Hibi I; Shizume K
    Horm Res; 1990; 33 Suppl 4():102-5. PubMed ID: 2147164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short stature in Noonan syndrome: response to growth hormone therapy.
    Kirk JM; Betts PR; Butler GE; Donaldson MD; Dunger DB; Johnston DI; Kelnar CJ; Price DA; Wilton P; Group tU
    Arch Dis Child; 2001 May; 84(5):440-3. PubMed ID: 11316696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose growth hormone treatment of short children born small for gestational age.
    de Zegher F; Maes M; Gargosky SE; Heinrichs C; Du Caju MV; Thiry G; De Schepper J; Craen M; Breysem L; Löfström A; Jönsson P; Bourguignon JP; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1996 May; 81(5):1887-92. PubMed ID: 8626853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone therapy in Silver Russell syndrome: 5 years experience of the Australian and New Zealand Growth database (OZGROW).
    Rakover Y; Dietsch S; Ambler GR; Chock C; Thomsett M; Cowell CT
    Eur J Pediatr; 1996 Oct; 155(10):851-7. PubMed ID: 8891553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with growth hormone therapy in Turner syndrome in a single centre: low total height gain, no further gains after puberty onset and unchanged body proportions.
    Schweizer R; Ranke MB; Binder G; Herdach F; Zapadlo M; Grauer ML; Schwarze CP; Wollmann HA
    Horm Res; 2000; 53(5):228-38. PubMed ID: 11150884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.
    Reiter EO; Lindberg A; Ranke MB; Price DA; Albertsson-Wikland K; Cowell CT; Bakker B
    Horm Res; 2003; 60(Suppl 1):68-73. PubMed ID: 12955021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Final height in short children born small for gestational age treated with growth hormone.
    Dahlgren J; Wikland KA;
    Pediatr Res; 2005 Feb; 57(2):216-22. PubMed ID: 15585685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutional delay in growth and puberty: a comparison of final height achieved between treated and untreated children.
    Ferrández Longás A; Mayayo E; Valle A; Soria J; Labarta JI
    J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():345-57. PubMed ID: 8887180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Final height and pubertal development in children with growth hormone deficiency after long-term treatment.
    Frisch H; Birnbacher R
    Horm Res; 1995; 43(4):132-4. PubMed ID: 7750913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A partial transient effect of short-term growth hormone (GH) treatment in short non-GH deficient prepubertal children.
    Low LC; Kwan E; Karlberg J
    J Pediatr Endocrinol Metab; 1995; 8(3):173-9. PubMed ID: 8521191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.